{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:30:23Z","timestamp":1793788223741,"version":"4.6.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHLT Open"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jhlto.2026.100627","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:25:09Z","timestamp":1783700709000},"page":"100627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inhaled pulmonary vasodilators in pulmonary hypertension: Perioperative use and clinical considerations"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8866-7143","authenticated-orcid":false,"given":"Rebecca","family":"Klingbeil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Hjalmarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailey","family":"Colvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Kozarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Bovill","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhlto.2026.100627_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01324-2024","article-title":"Definition, classification and diagnosis of pulmonary hypertension","volume":"64","author":"Kovacs","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jhlto.2026.100627_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.5856","article-title":"Inhaled pulmonary vasodilator therapy in adult lung transplant: a randomized clinical trial","volume":"157","author":"Ghadimi","year":"2022","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jhlto.2026.100627_bib3","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1164\/rccm.202302-0327SO","article-title":"Pulmonary hypertension: a contemporary review","volume":"208","author":"Johnson","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jhlto.2026.100627_bib4","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.healun.2022.06.013","article-title":"ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery","volume":"41","author":"McGlothlin","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jhlto.2026.100627_bib5","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1161\/CIR.0000000000001136","article-title":"Evaluation and management of pulmonary hypertension in noncardiac surgery: a scientific statement from the American Heart Association","volume":"147","author":"Rajagopal","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2026.100627_bib6","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.amjcard.2019.02.006","article-title":"Cardiovascular outcomes of patients with pulmonary hypertension undergoing noncardiac surgery","volume":"123","author":"Smilowitz","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jhlto.2026.100627_bib7","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/CIRCULATIONAHA.116.023262","article-title":"Cardiovascular and ventilatory consequences of laparoscopic surgery","volume":"135","author":"Atkinson","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2026.100627_bib8","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/s12630-024-02770-w","article-title":"Novel inhaled pulmonary vasodilators in adult cardiac surgery: a scoping review","volume":"71","author":"David","year":"2024","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jhlto.2026.100627_bib9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4103\/0971-9784.159811","article-title":"Inhaled therapy for the management of perioperative pulmonary hypertension","volume":"18","author":"Thunberg","year":"2015","journal-title":"Ann Card Anaesth"},{"key":"10.1016\/j.jhlto.2026.100627_bib10","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s12630-023-02520-4","article-title":"The perioperative use of inhaled prostacyclins in cardiac surgery: a systematic review and meta-analysis","volume":"70","author":"Marcus","year":"2023","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jhlto.2026.100627_bib11","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1093\/eurheartj\/ehaa187","article-title":"Sir John Vane 1927-2004","volume":"41","author":"Ozkan","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jhlto.2026.100627_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13020564","article-title":"Inhaled pulmonary vasodilators for the treatment of right ventricular failure in cardio-thoracic surgery: is one better than the others?","volume":"13","author":"Benedetto","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhlto.2026.100627_bib13","doi-asserted-by":"crossref","first-page":"597","DOI":"10.21037\/atm-20-4895","article-title":"Inhaled pulmonary vasodilators: a narrative review","volume":"9","author":"Liu","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jhlto.2026.100627_bib14","unstructured":"Administration FD: INOMAX (nitric oxide) gas, for inhalation. Federal Drug Administration; 2019."},{"key":"10.1016\/j.jhlto.2026.100627_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/cc9264","article-title":"Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review","volume":"14","author":"Price","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.jhlto.2026.100627_bib16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1164\/ajrccm.159.2.9804127","article-title":"Response to inhaled nitric oxide in patients with acute right heart syndrome","volume":"159","author":"Bhorade","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jhlto.2026.100627_bib17","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/00007890-200108270-00013","article-title":"Inhaled nitric oxide for pulmonary hypertension after heart transplantation","volume":"72","author":"Ardehali","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jhlto.2026.100627_bib18","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1164\/rccm.2108121","article-title":"Dose-response characteristics during long-term inhalation of nitric oxide in patients with severe acute respiratory distress syndrome: a prospective, randomized, controlled study","volume":"167","author":"Gerlach","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jhlto.2026.100627_bib19","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.amjcard.2010.11.030","article-title":"Comparison of inhaled nitric oxide versus oxygen on hemodynamics in patients with mitral stenosis and severe pulmonary hypertension after mitral valve surgery","volume":"107","author":"Fernandes","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jhlto.2026.100627_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0952-8180(01)00270-7","article-title":"Dose response to nitric oxide in adult cardiac surgery patients","volume":"13","author":"Solina","year":"2001","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.jhlto.2026.100627_bib21","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jtcvs.2009.04.063","article-title":"A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients","volume":"138","author":"Khan","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jhlto.2026.100627_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1060028015608865","article-title":"A comparison of inhaled nitric oxide versus inhaled epoprostenol for acute pulmonary hypertension following cardiac surgery","volume":"50","author":"McGinn","year":"2016","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jhlto.2026.100627_bib23","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1161\/CIRCULATIONAHA.122.062464","article-title":"Inhaled epoprostenol compared with nitric oxide for right ventricular support after major cardiac surgery","volume":"148","author":"Ghadimi","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jhlto.2026.100627_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhlto.2026.100516","article-title":"A retrospective pilot crossover study of protocolized transition from inhaled nitric oxide to inhaled epoprostenol in adult cardiothoracic surgery","volume":"12","author":"Meyer","year":"2026","journal-title":"JHLT Open"},{"key":"10.1016\/j.jhlto.2026.100627_bib25","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/00000542-200310000-00017","article-title":"Effect of nitroglycerin inhalation on patients with pulmonary hypertension undergoing mitral valve replacement surgery","volume":"99","author":"Yurtseven","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jhlto.2026.100627_bib26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/0971-9784.62946","article-title":"Acute hemodynamic effects of inhaled nitroglycerine, intravenous nitroglycerine, and their combination with intravenous dobutamine in patients with secondary pulmonary hypertension","volume":"13","author":"Mandal","year":"2010","journal-title":"Ann Card Anaesth"},{"key":"10.1016\/j.jhlto.2026.100627_bib27","first-page":"319","article-title":"A comparison of the acute hemodynamic effects of inhaled nitroglycerin and iloprost in patients with pulmonary hypertension undergoing mitral valve surgery","volume":"12","author":"Yurtseven","year":"2006","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jhlto.2026.100627_bib28","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1067\/mtc.2003.107","article-title":"Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery","volume":"125","author":"Hach\u00e9","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jhlto.2026.100627_bib29","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jtcvs.2003.11.035","article-title":"Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery","volume":"127","author":"De Wet","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jhlto.2026.100627_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.jvca.2014.06.012","article-title":"Preliminary experience with combined inhaled milrinone and prostacyclin in cardiac surgical patients with pulmonary hypertension","volume":"29","author":"Laflamme","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jhlto.2026.100627_bib31","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1213\/ANE.0000000000006192","article-title":"Pulmonary vasodilator response of combined inhaled epoprostenol and inhaled milrinone in cardiac surgical patients","volume":"136","author":"Elmi-Sarabi","year":"2023","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jhlto.2026.100627_bib32","doi-asserted-by":"crossref","DOI":"10.1213\/ANE.0000000000004793","article-title":"Routine intraoperative inhaled milrinone and iloprost reduces inotrope use in patients undergoing cardiac surgery: a retrospective cohort pilot study","volume":"131","author":"Hu","year":"2020","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jhlto.2026.100627_bib33","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1053\/j.jvca.2007.10.015","article-title":"Comparison of inhaled iloprost and nitric oxide in patients with pulmonary hypertension during weaning from cardiopulmonary bypass in cardiac surgery: a prospective randomized trial","volume":"22","author":"Winterhalter","year":"2008","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jhlto.2026.100627_bib34","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s12630-016-0709-8","article-title":"A multicentre randomized-controlled trial of inhaled milrinone in high-risk cardiac surgical patients","volume":"63","author":"Denault","year":"2016","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jhlto.2026.100627_bib35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cardfail.2023.08.025","article-title":"Novel nebulized milrinone formulation for the treatment of acute heart failure requiring inotropic therapy: a phase 1 study","volume":"30","author":"Cox","year":"2024","journal-title":"J Cardiac Fail"},{"key":"10.1016\/j.jhlto.2026.100627_bib36","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1038\/s41598-020-58902-x","article-title":"Inhaled milrinone in cardiac surgical patients: a pilot randomized controlled trial of jet vs. mesh nebulization","volume":"10","author":"Nguyen","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhlto.2026.100627_bib37","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s12325-009-0019-4","article-title":"Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery","volume":"26","author":"Wang","year":"2009","journal-title":"Adv Ther"},{"key":"10.1016\/j.jhlto.2026.100627_bib38","first-page":"3369","article-title":"Intraoperative efficacy of brief inhalation of milrinone on elevated pulmonary arterial pressure in patients undergoing mitral valve surgery due to mitral regurgitation","volume":"20","author":"Kim","year":"2014","journal-title":"Exp Clin Cardiol"},{"key":"10.1016\/j.jhlto.2026.100627_bib39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/0218492320970015","article-title":"Inhaled versus intravenous milrinone in mitral stenosis with pulmonary hypertension","volume":"29","author":"Patel","year":"2021","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1016\/j.jhlto.2026.100627_bib40","doi-asserted-by":"crossref","DOI":"10.5812\/aapm-122994","article-title":"Comparison of nebulized versus intravenous milrinone on reducing pulmonary arterial pressure in patients with pulmonary hypertension candidate for open-cardiac surgery: a double-blind randomized clinical trial","volume":"12","author":"Jorairahmadi","year":"2022","journal-title":"Anesth Pain Med"},{"key":"10.1016\/j.jhlto.2026.100627_bib41","first-page":"38","article-title":"Comparison of hemodynamic effects of inhaled milrinone and inhaled prostacyclin after adult cardiac surgery","volume":"6","author":"Hegazy","year":"2010","journal-title":"J Appl Sci Res"},{"key":"10.1016\/j.jhlto.2026.100627_bib42","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/s00380-017-1023-2","article-title":"A retrospective comparison of inhaled milrinone and iloprost in post-bypass pulmonary hypertension","volume":"32","author":"Theodoraki","year":"2017","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jhlto.2026.100627_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2021.110231","article-title":"The direct comparison of inhaled versus intravenous levosimendan in children with pulmonary hypertension undergoing on-cardiopulmonary bypass cardiac surgery: A randomized, controlled, non-inferiority study","volume":"71","author":"Abdelbaser","year":"2021","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.jhlto.2026.100627_bib44","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s12872-025-04967-3","article-title":"Innovative nitric oxide delivery technology for postoperative pulmonary hypertension in congenital heart disease patients: a clinical trial","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jhlto.2026.100627_bib45","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1164\/rccm.201304-0686PP","article-title":"Nitric oxide deficiency and endothelial dysfunction in pulmonary arterial hypertension","volume":"188","author":"Klinger","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jhlto.2026.100627_bib46","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1053\/j.jvca.2017.12.014","article-title":"Inhaled nitric oxide (iNO) and inhaled epoprostenol (iPGI(2)) use in cardiothoracic surgical patients: is there sufficient evidence for evidence-based recommendations?","volume":"32","author":"Rao","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jhlto.2026.100627_bib47","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4187\/respcare.03927","article-title":"Inhaled therapies for pulmonary hypertension","volume":"60","author":"Hill","year":"2015","journal-title":"Respir Care"},{"key":"10.1016\/j.jhlto.2026.100627_bib48","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s40256-014-0093-0","article-title":"Epoprostenol (Veletri\u00ae, Caripul\u00ae): a review of its use in patients with pulmonary arterial hypertension","volume":"14","author":"Greig","year":"2014","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jhlto.2026.100627_bib49","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s40262-016-0409-0","article-title":"A comprehensive review of treprostinil pharmacokinetics via four routes of administration","volume":"55","author":"Kumar","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jhlto.2026.100627_bib50","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02414-2022","article-title":"Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study","volume":"61","author":"Waxman","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jhlto.2026.100627_bib51","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1378\/chest.124.4.1294","article-title":"Pharmacodynamics and pharmacokinetics of inhaled iloprost, aerosolized by three different devices, in severe pulmonary hypertension","volume":"124","author":"Olschewski","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.jhlto.2026.100627_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2021.110337","article-title":"Inhaled levosimendan: new opportunities with an old drug","volume":"73","author":"Evans","year":"2021","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.jhlto.2026.100627_bib53","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.healun.2007.01.035","article-title":"Management of pulmonary arterial hypertension with a focus on combination therapies","volume":"26","author":"Benza","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jhlto.2026.100627_bib54","doi-asserted-by":"crossref","DOI":"10.1213\/ANE.0000000000002138","article-title":"Aerosolized vasodilators for the treatment of pulmonary hypertension in cardiac surgical patients: a systematic review and meta-analysis","volume":"125","author":"Elmi-Sarabi","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jhlto.2026.100627_bib55","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1053\/j.jvca.2023.07.041","article-title":"Pulmonary vasodilator and inodilator drugs in cardiac surgery: a systematic review with bayesian network meta-analysis","volume":"37","author":"Sardo","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jhlto.2026.100627_bib56","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1053\/j.jvca.2025.12.008","article-title":"Combined inhaled pulmonary vasodilators in cardiac surgery: a scoping review","volume":"40","author":"Soto","year":"2026","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jhlto.2026.100627_bib57","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1053\/j.jvca.2021.11.005","article-title":"Inhaled pulmonary vasodilator utilization and cost following initiation of a protocol in a Quaternary Academic Heart Center Intensive Care Unit","volume":"36","author":"Austin","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jhlto.2026.100627_bib58","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1089253219870636","article-title":"Inhaled pulmonary vasodilators and thoracic organ transplantation: does evidence support its use and cost benefit?","volume":"24","author":"Krebs","year":"2020","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jhlto.2026.100627_bib59","doi-asserted-by":"crossref","DOI":"10.1177\/20458940211057071","article-title":"TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension","volume":"11","author":"Frantz","year":"2021","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jhlto.2026.100627_bib60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/jamp.2020.1651","article-title":"Safety, tolerability, and pharmacokinetics of RT234 (Vardenafil Inhalation Powder): a first-in-human, ascending single- and multiple-dose study in healthy subjects","volume":"34","author":"Eldon","year":"2021","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.jhlto.2026.100627_bib61","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhlto.2026.100627_bib62","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1209657","article-title":"Riociguat for the treatment of chronic thromboembolic pulmonary hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jhlto.2026.100627_bib63","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.rmed.2016.11.010","article-title":"sGC stimulators: evidence for riociguat beyond groups 1 and 4 pulmonary hypertension","volume":"122","author":"Benza","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.jhlto.2026.100627_bib64","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2147\/DDDT.S117277","article-title":"Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension","volume":"11","author":"Lian","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jhlto.2026.100627_bib65","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01110-2024","article-title":"MK-5475, an inhaled soluble guanylate cyclase stimulator, for treatment of pulmonary arterial hypertension: the INSIGNIA-PAH study","volume":"64","author":"Humbert","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jhlto.2026.100627_bib66","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1183\/09031936.00126010","article-title":"Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats","volume":"37","author":"Dumitrascu","year":"2011","journal-title":"Eur Respir J"}],"container-title":["JHLT Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133426001485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133426001485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:13:50Z","timestamp":1793787230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950133426001485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":66,"alternative-id":["S2950133426001485"],"URL":"https:\/\/doi.org\/10.1016\/j.jhlto.2026.100627","relation":{},"ISSN":["2950-1334"],"issn-type":[{"value":"2950-1334","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhaled pulmonary vasodilators in pulmonary hypertension: Perioperative use and clinical considerations","name":"articletitle","label":"Article Title"},{"value":"JHLT Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhlto.2026.100627","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}],"article-number":"100627"}}